Both in Medical Labs
Sera Prognostics vs Freenome
Over the past year SERA returned −0.7% and FRNM returned −21.4%; their daily moves had a correlation of -0.02.
SERA −0.7% FRNM −21.4%Growth of $1, one year, split-adjusted
| Metric | SERA | FRNM |
|---|---|---|
| Price | $2.02 | $11.30 |
| Market cap | $79.5M | $1.21B |
| Today | +4.40% | −1.48% |
| 1 month | −1.7% | −30.9% |
| 6 months | +11.3% | — |
| Year to date | −31.7% | — |
| 1 year | −37.0% | — |
| Revenue growth (YoY) | +76.5% | — |
| Gross margin | −66.7% | — |
| Net margin | −30463.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 1,135.6× | — |
| Net cash | $46.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | — |
| Short % of float | 0.7% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).